NSN 6505-01-197-4180 of Labetalol Hydrochlo - Parts Details
| Alternative NSN: 6505011974180 |
| Item Name: Labetalol Hydrochlo |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 011974180 |
| NCB Code: USA (01) |
| Manufacturers: Glaxowellcome , Baxter Healthcare Ltd , Danbury Pharmacal Inc , Sandoz Inc , Eon Labs Llc , Zenith Laboratories Inc , Schering Plough Ltd |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC60976-0348-43, NDC00677-1703-01, NDC00591-0607-01, NDC00185-0118-01, NDC00173-0348-43 under NSN 6505-01-197-4180 of Labetalol Hydrochlo manufactured by Glaxowellcome, Baxter Healthcare Ltd, Danbury Pharmacal Inc, Sandoz Inc, Eon Labs Llc.
Federal Supply Class of NSN 6505-01-197-4180 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-197-4180, 6505011974180
-
Part No Manufacturer Item Name QTY RFQ NDC60976-0348-43 Glaxowellcome labetalol hydrochlo Avl RFQ NDC00677-1703-01 Baxter Healthcare Ltd labetalol hydrochlo Avl RFQ NDC00591-0607-01 Danbury Pharmacal Inc labetalol hydrochlo Avl RFQ NDC00185-0118-01 Sandoz Inc labetalol hydrochlo Avl RFQ NDC00185-0118-01 Eon Labs Llc labetalol hydrochlo Avl RFQ NDC00173-0348-43 Glaxowellcome labetalol hydrochlo Avl RFQ NDC00172-4366-60 Zenith Laboratories Inc labetalol hydrochlo Avl RFQ NDC00085-0438-03 Schering Plough Ltd labetalol hydrochlo Avl RFQ
Characteristics Data of NSN 6505011974180MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 300.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT BLGJ COATING FEATURE FILM, NONENTERIC CQCT PRIMARY CONTAINER TYPE BOTTLE CRLK PRIMARY CONTAINER CONTENT QUANTITY 100.000 TABLETS CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY LABETALOL HYDROCHLORIDE TABLETS 300MG 100S BT MDES MEDICAL DESIGNATION UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT |
| BLGJ | COATING FEATURE | FILM, NONENTERIC |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | LABETALOL HYDROCHLORIDE TABLETS 300MG 100S BT |
| MDES | MEDICAL DESIGNATION | UNITED STATES PHARMACOPEIA |